DEBRA RUSSELL: Open Payments
NPI 1871836858 · ELBERTA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$828 in 30 payments from 9 companies in 2025. Trend: 2023 $848 · 2024 $883 · 2025 $828
Food & beverage: $828
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $352 |
| Exact Sciences Corporation | 3 | $158 |
| Novo Nordisk Inc | 4 | $79 |
| Lilly USA, LLC | 4 | $74 |
| ABBVIE INC. | 4 | $72 |
| Viatris Specialty LLC | 2 | $36 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: AIRSUPRA, The Cologuard Plus Collection Kit, FARXIGA, VRAYLAR, MOUNJARO, YUPELRI, KISUNLA, GEMTESA.
Industry payments across AL — which companies pay providers there.
